| Serial Number | 79354042 |
| Word Mark | SINTETOL |
| Filing Date | Wednesday, September 7, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, February 6, 2024 |
| Registration Number | 7296144 |
| Registration Date | Tuesday, February 6, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 21, 2023 |
| Goods and Services | Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer; drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of respiratory system disorders; drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; pharmaceutical preparations for the prevention and treatment of respiratory system disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; biological preparations for medical purposes for the prevention and treatment of infectious diseases, pain, cancer and tumors; vaccines; medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer and antibiotics; medicines for human purposes for the prevention and treatment of respiratory system disorders; medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; medicines for human purposes for the prevention and treatment of infectious diseases, pain, cancer and tumors; diagnostic preparations for medical purposes; absorbent wadding for medical purposes |
| Goods and Services | Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies, except dietary supplements; wholesale distributorship services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies, except dietary supplements; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies, except dietary supplements; retail and wholesale store services featuring pharmaceutical preparations, except dietary supplements; marketing services; commercial administration of the licensing of the goods and services of others; providing television home shopping services in the field of general consumer merchandise; advertising services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 4, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 4, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Zhuhai Trinomab Pharmaceutical Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Zhuhai Trinomab Pharmaceutical Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Zhuhai Trinomab Pharmaceutical Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Event Date | Event Description |
| Thursday, November 3, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, November 4, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 8, 2022 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, April 26, 2023 | ASSIGNED TO EXAMINER |
| Thursday, April 27, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, April 28, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, June 8, 2023 | REFUSAL PROCESSED BY MPU |
| Thursday, June 8, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, July 4, 2023 | REFUSAL PROCESSED BY IB |
| Friday, September 22, 2023 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Wednesday, October 11, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 11, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 12, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 19, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 1, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, November 1, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, November 1, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Tuesday, November 21, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 21, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 6, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 6, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, November 21, 2023 | NOTIFICATION PROCESSED BY IB |
| Monday, May 6, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Saturday, May 11, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| Sunday, June 2, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Saturday, May 11, 2024 | FINAL DISPOSITION PROCESSED |